抗真菌薬の北米市場

◆英語タイトル:North America Antifungal Drugs Market Forecast 2017-2025
◆商品コード:INKW709012
◆発行会社(調査会社):Inkwood Research
◆発行日:2017年9月1日
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:北米
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

KEY FINDINGSThe North America antifungal drugs market is anticipated to grow at a CAGR of 1.27% in the forecasted period of 2017-2025. The market was valued at $5278 million in 2016 and is expected to grow $5925 million by 2025. Initiatives taken by the government in healthcare policies and programs are some of the factors helping the market to surge ahead.
MARKET INSIGHTS
The antifungal drugs market segmentation by therapeutic indications on the basis of Aspergillosis, Dermatophytosis and Candidiasis market. It is further segmented by drug types on the basis of Echinocandins market, Azoles market, Polyenes market, Allylamines and others. It is further divided by applications on the basis of topical antifungal drugs and Oral drugs market. Poor hygiene and development in the exclusive drug resistance are the factors responsible for the growth of the antifungal market in the region. Alternation in the treatment options and conditions in regulation are the restraints faced by the anti-fungal market in North America region.
COMPETITIVE INSIGHTS
The major market players in the antifungal drugs market are Abbott Laboratories, Arbor Pharmaceuticals INC., Baxter, AstellasPharma Inc., Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck Co, Novartis and Pfizer, Sanofi- Aventis, Vertex Pharmaceuticals.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. POOR HYGIENE HABITS
4.1.2. DEVELOPMENT OF DRUG RESISTANCE
4.1.3. HEALTHCARE POLICIES AND PROGRAMS BY GOVERNMENT
4.2. RESTRAINTS
4.2.1. ALTERNATE TREATMENT OPTIONS
4.2.2. REGULATORY ATMOSPHERE
4.3. OPPORTUNITIES
4.3.1. HEALTHCARE AND RELATED INDUSTRIES ARE GROWING CONTINUOUSLY
4.3.2. INCREASING AWARENESS AND AVAILABILITY OF INFORMATION
4.4. CHALLENGES
4.4.1. SIDE EFFECTS AND RECURRING FUNGAL INFECTIONS
4.4.2. RESISTANCE TO DRUG
4.4.3. RAPIDLY CHANGING TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY DRUG TYPES
5.1.1. ECHINOCANDINS MARKET
5.1.2. AZOLES MARKET
5.1.3. POLYENES MARKET
5.1.4. ALLYLAMINES MARKET
5.1.5. OTHERS MARKET
5.2. BY THERAPEUTIC INDICATIONS
5.2.1. ASPERGILLOSIS MARKET
5.2.2. DERMATOPHYTOSIS MARKET
5.2.3. CANDIDIASIS MARKET
5.2.4. OTHERS MARKET
5.3. BY APPLICATIONS
5.3.1. TOPICAL ANTIFUNGAL DRUGS MARKET
5.3.2. ORAL DRUGS MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. KEY BUYING CRITERIA
6.4. VALUE CHAIN ANALYSIS
6.5. STRATEGIC RECOMMENDATION
6.6. STRATEGIC CONCLUSIONS
6.7. OPPORTUNITY MATRIX
6.8. VENDOR LANDSCAPE
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA ANTIFUNGAL DRUGS MARKET
7.1.1. UNITED STATES ANTIFUNGAL DRUGS MARKET
7.1.2. CANADA ANTIFUNGAL DRUGS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC INITIATIVES
9.2. ARBOR PHARMACEUTICALS, INC.
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. SCOT ANALYSIS
9.2.4. STRATEGIC INITIATIVES
9.3. 3 BAXTER
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. SCOT ANALYSIS
9.3.4. STRATEGIC INITIATIVES
9.4. ASTELLAS PHARMA INC.
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. SCOT ANALYSIS
9.4.4. STRATEGIC INITIATIVES
9.5. BAYER HEALTHCARE
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. SCOT ANALYSIS
9.5.4. STRATEGIC INITIATIVE
9.6. TEVA PHARMACEUTICALS
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. SCOT ANALYSIS
9.6.4. STRATEGIC INITIATIVES
9.7. GILEAD
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. SCOT ANALYSIS
9.7.4. STRATEGIC INITIATIVES
9.8. GLAXOSMITHKLINE
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC MOVES
9.9. JOHNSON & JOHNSON
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. SCOT ANALYSIS
9.9.4. STRATEGIC MOVES
9.10. KRAMER LABORATORIES
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.11. MERCK & CO.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. SCOT ANALYSIS
9.11.4. STRATEGIC MOVES
9.12. NOVARTIS
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC MOVES
9.13. PFIZER
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC MOVES
9.14. SANOFI-AVENTIS
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. SCOT ANALYSIS
9.14.4. STRATEGIC INITIATIVE
9.15. VERTEX PHARMACEUTICALS
9.15.1. OVERVIEW
9.15.2. PRODUCT PORTFOLIO
9.15.3. SCOT ANALYSIS
9.15.4. STRATEGIC INITIATIVE

TABLE LIST

TABLE # 1 INDICATION AND DOSES OF ECHINOCANDIN
TABLE # 2 NORTH AMERICA ECHINOCANDINS MARKET 2017-2025 ($ MILLION)
TABLE # 3 DRUG USES OF TRIAZOLES
TABLE # 4 NORTH AMERICA AZOLES MARKET 2017-2025 ($ MILLION)
TABLE # 5 NORTH AMERICA POLYENES MARKET 2017-2025 ($ MILLION)
TABLE # 6 PRICE OF ALLYLAMINE ANTIFUNGALS
TABLE # 7 NORTH AMERICA ALLYLAMINES MARKET 2017-2025 ($ MILLION)
TABLE # 8 NORTH AMERICA ASPERGILLOSIS MARKET 2017-2025 ($ MILLION)
TABLE # 9 COMMON AFFECTED AREA – DERMATOPHYTES
TABLE # 10 NORTH AMERICA DERMATOPHYTOSIS MARKET 2017-2025 ($ MILLION)
TABLE # 11 SYMPTOMS IN THE AFFECTED AREA CAUSED BY CANDIDIASIS
TABLE # 12 NORTH AMERICA CANDIDIASIS MARKET 2017-2025 ($ MILLION)
TABLE # 13 NORTH AMERICA OTHERS MARKET 2017-2025 ($ MILLION)
TABLE # 14 PROS AND CONS OF TOPICAL MEDICATIONS
TABLE # 15 BRANDS OF ANTIFUNGAL POWDERS AND THEIR FUNCTIONALITY
TABLE # 16 BRANDS OF ANTIFUNGAL OINTMENTS AND THEIR FUNCTIONALITY
TABLE # 17 ANTIFUNGAL PASTES AND ITS EFFECT
TABLE # 18 COMMONLY USED ANTIFUNGAL DRUGS DOSAGE AND IT’S EFFECTS
TABLE # 19 NORTH AMERICA ANTI-FUNGAL MARKET BY REGION 2017-2025 ($ MILLION)

FIGURES LIST
FIGURE # 1 ALTERNATIVE MEDICINE IN US (IN MILLION US DOLLARS)
FIGURE # 2 HEALTHCARE INDUSTRY IN THE WORLD IS RAPIDLY GROWING (%)
FIGURE # 3 NORTH AMERICA ECHINOCANDINS MARKET 2017-2025 ($ MILLION)
FIGURE # 4 NORTH AMERICA AZOLES MARKET 2017-2025 ($ MILLION)
FIGURE # 5 NORTH AMERICA POLYENES MARKET 2017-2025 ($ MILLION)
FIGURE # 6 NORTH AMERICA ALLYLAMINES MARKET 2017-2025 ($ MILLION)
FIGURE # 7 NORTH AMERICA OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE # 8 NORTH AMERICA ASPERGILLOSIS MARKET 2017-2025 ($ MILLION)
FIGURE # 9 NORTH AMERICA DERMATOPHYTOSIS MARKET 2017-2025 ($ MILLION)
FIGURE # 10 NORTH AMERICA CANDIDIASIS MARKET 2017-2025 ($ MILLION)
FIGURE # 11 NORTH AMERICA OTHERS MARKET 2017-2025 ($ MILLION)
FIGURE # 12 TOPICAL ANTIFUNGAL DRUGS TYPES
FIGURE # 13 NORTH AMERICA TOPICAL ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)
FIGURE # 14 NORTH AMERICA ORAL DRUGS MARKET 2017-2025 ($ MILLION)
FIGURE # 15 PORTER’S FIVE FORCE MODEL IN ANTIFUNGAL DRUGS MARKET
FIGURE # 16 HEALTHCARE INVESTMENT IN THE U.S. 2012-2015 ($ BILLION)
FIGURE # 17 ANTI-FUNGAL DRUGS MARKET IN THE U.S. 2017-2025 ($ MILLION)
FIGURE # 18 CANADA ANTIFUNGAL DRUGS MARKET 2017-2025 ($ MILLION)



【レポートのキーワード】

抗真菌薬

★調査レポート[抗真菌薬の北米市場] (コード:INKW709012)販売に関する免責事項を必ずご確認ください。
★調査レポート[抗真菌薬の北米市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆